Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

UCB wins European approval for epilepsy drug Briviact

Plans first launches within weeks

- PMLiVE

Acorda acquires Biotie to expand in Parkinson’s disease

Strikes $363m deal for Finnish firm

- PMLiVE

Merck KGaA adds two to its executive board

Appoints Udit Batra and Walter Galinat, while Bernd Reckmann will retire

- PMLiVE

Audit office says FDA ‘is not meeting safety data obligations’

Criticised for not effectively tracking information about approved drugs

- PMLiVE

Germany’s Merck triumphs in court battle with US namesake

English court rules Merck & Co breached the firms' naming agreement

EISAI

Eisai’s Lenvima gets FDA priority review for kidney cancer

The oncology treatment could now be approved in the US before the summer

- PMLiVE

David Kendall joins Alimentary Health

He will take up to role of business development director UK

Lucid’s digital responsibility: delivering value by improving patient outcomes

Digital initiatives must address your customer's needs

Lucid Group Communications Limited

Weber Shandwick acquires US healthcare communications firm

Strikes deal with ReviveHealth in bid to boost its integrated health comms services

Why are we still talking about multichannel?

Interview with Sebastian Kölsch, Chief Solutions Officer at Anthill.

Anthill Agency

EU flag

Biogen-Samsung’s Enbrel biosimilar cleared for EU marketing

The companies plan to launch the treatment in the coming weeks

- PMLiVE

GalbraithWight appoints Eithne McShane and Steve Mazzarese

They join the market access consultancy as global business development directors

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links